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Abstract: The influenza virus enters target cells via the action of 
hemagglutinin proteins (HA) inserted into the viral envelope. HA promotes 
membrane fusion between the viral envelope and endosomal membrane at low 
pH, following viral binding to sialic acid-containing receptors on target cells, 
and internalization by endocytosis. The effect of target membrane sialic acid 
residues on the fusion activity of the influenza virus towards model 
membranes was evaluated by both reduction, (i.e. treating somatic cells with 
neuraminidase- (NA-) prior to virus-cell interactions), and by supplementing 
liposomes with the gangliosides GD1a and GT1b. The harshness of the 
neuraminidase pretreatment of target cells required to affect virus-induced 
membrane merging was found to greatly depend on the assay conditions, i.e. 
whether a virus-cell prebinding step at neutral pH was included prior to 
acidification. Minor concentrations of neuraminidase were found to greatly 
reduce virus fusion, but only in the absence of a prebinding step; they had no 
effect if this step was included. Although membrane merging was greatly 
reduced following cell neuraminidase pretreatment, virus-cell association at 
low pH was not disturbed proportionately. This probably reflects unspecific 
virus-cell binding under these conditions, probably of inactivated or 
aggregated virus particles, which does not translate into membrane merging. 
This seems to suggest both that target membrane sialic acid can protect the 
virus from losing its activity before triggering membrane merging, and that the 
importance of this interaction is not merely to ensure virus-target proximity. 
With liposomes, we found that both types of ganglioside supported efficient 
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fusion, with GD1a promoting a slightly faster initial rate. However, in this 
case, virus-target proximity closely mirrored fusion activity, thus pointing to 
differential specificity between targets routinely used to assay influenza virus 
fusion activity. 
 
Key Words: Influenza Virus, Membrane Fusion, Sialic Acid, Gangliosides, 
Liposomes 
 
INTRODUCTION 
 
The influenza virus enters its target cells by first binding to sialic acid residues 
on the cell surface, and subsequently being internalized by receptor-mediated 
endocytosis, and then delivered to endosomes. Viral access to the cytosol 
occurs following fusion between the viral envelope and the endosomal 
membrane, an event that is triggered by conformational changes in the 
envelope hemagglutinin (HA) at the acidic pH (±5.0) normally found in the 
endosomal lumen (for reviews see [1-3]). HA is a homotrimeric glycoprotein 
synthesized as an inactive precursor (designated HA0) in infected cells; it only 
becomes functionally active following proteolytic cleavage, which results into 
two distinct subunits (HA1 and HA2) linked by disulfide bonds. The low pH-
induced conformational change includes dramatic changes in the membrane-
bound HA2 subunits, the result of which is the exposure of a short N-terminal 
hydrophobic peptide that is projected into the medium and inserted into the 
target membrane. The insertion of the “fusion peptide” is thought to mediate 
physical changes in the apposing lipid-bilayers, thus bridging them and 
facilitating membrane merging (for reviews see [2-4]). Interestingly, if the 
conformational change cannot be translated into membrane fusion (i.e., if it 
takes place in the absence of any target membrane, for example) the viral HA 
quickly and irreversibly loses its membrane-perturbing qualities, a process 
dubbed “viral inactivation” [5], although some studies suggest both that the 
HA can retain some fusogenic ability following inactivation [6], and that at 
least some aspects of the low pH-induced conformational change may be 
reversible [7, 8]. It is also worth noting that most studies have been performed 
in “bulk” systems (i.e. looking at and averaging out the activity of many HA 
trimers), and that only a few molecules may actually participate in membrane 
merging, and thus undergo physiologically relevant changes [1, 9]. 
Much attention has focused on the later (i.e. HA2-dependent) steps in 
influenza virus-mediated membrane fusion. However, relatively little attention 
has been paid to the initial contact between HA1 and the target membrane [27, 
29], and on the influence this interaction may ultimately have on membrane 
merging, possibly by accurately positioning a sufficient number of trimers 
relative to the endosome membrane. It has been found that target membrane 
components modulate the fusion activity of lipid-enveloped viruses by 
interfering with HA interactions with cellular membranes [10, 11] Indeed, it 
has been proposed that target membrane sialic acid residues, which modulate 
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influenza virus binding to target cells, play a role in the membrane fusion step 
itself [10]. We have addressed this issue by applying a dual experimental 
approach, and studying the binding and fusion activity of the influenza virus to 
two types of target membrane: on the one hand, cells from which sialic acid 
moieties were removed following neuraminidase treatment; and, on the other, 
artificial target membranes (liposomes) supplemented with different types of 
gangliosides. Viral fusion activity towards these two types of target 
membranes was determined using the octadecylrhodamine B chloride (R18) 
fluorescence dequenching assay [5, 6, 12].  
 
MATERIALS & METHODS 
 
Chemicals 
All the chemicals used were obtained from the Sigma Chemical Company (St 
Louis, MO), unless stated otherwise.  
 
Virus 
The A/PR/8/34 (H1N1) strain of the influenza virus was grown for 48 h at 
37ºC in the allantoic cavity of 11-day-old embryonated eggs, purified by 
discontinuous sucrose density gradient centrifugation and stored at -70ºC in 
phosphate buffered saline.  
 
Cells  
CEM cells were donated by Dr. Nejat Duzgunes (University of the Pacific 
School of Dentistry, San Francisco CA). Cells were grown in a RPMI 1640 
medium containing 25 mM Hepes, supplemented with 10% foetal bovine 
serum and antibiotics. Cells were grown in T-75 flasks up to a cell density of 
1-1.5x106/ml under a 5% CO2 atmosphere in a Forma Scientific incubator. For 
experimental purposes, the cells were harvested by centrifugation at 180xg for 
8 min at room temperature, washed twice in PBS, once in phenol red-free 
RPMI 1640 supplemented with 25 mM Hepes (Medium A), and resuspended 
in the latter medium. Cell viability was determined by Trypan blue extrusion, 
and was routinely above 95%. CEM cells were used since they exhibit very 
low endocytic ability [10], and thus virus-cell interactions take place solely at 
the plasma membrane level. 
 
Liposome preparation 
Phospholipids were obtained from Avanti Polar Lipids (Alabaster, AL). 
Liposomes (LUVs – large unilamellar vesicles), composed of 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) in a 2:1 molar 
ratio, and containing 5 mol % of the gangliosides GD1a or GT1b, were 
prepared in 85 mM NaCl, 50 mM KCl, 1mM EDTA, 10 mM Hepes, 10 mM 
Mes, 10 mM sodium citrate, buffered at pH 7.4 (Medium B) by the reverse-
phase evaporation method [13]. The vesicles were sized through 0.1 µm 
polycarbonate filters, and their concentration was determined by a phosphate 
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assay. Multilamellar vesicles (MLVs) were prepared by gently rehydrating 
dried lipid films with Medium B. 
 
Virus labeling 
Influenza virus samples were labeled with the fluorescent probe 
octadecylrhodamine B chloride (R18; Molecular Probes Inc., Eugene, OR) at  
a selfquenching concentration, as described previously [5, 6, 12]. The final 
concentration of added probe corresponded to approximately 5 mole % of the 
total viral lipid, and that of ethanol was less than 1% (v/v). The mixture was 
incubated in the dark for 30 min at room temperature. R18-labeled virus was 
separated from non-inserted fluorophore by chromatography on Sephadex G-
75 (Pharmacia, Uppsala, Sweden) using 150 mM NaCl, 10 mM Hepes, pH 7.4 
as an elution buffer. The protein concentration of the labeled virus was 
determined using the Lowry assay. 
 
Viral fusion activity 
Fusion was monitored continuously at 37ºC as a function of R18 fluorescence 
dequenching, dependent on probe dilution into a target membrane upon virus 
fusion [5, 6, 12]. For experiments with CEM cells, influenza virus (2 µg of 
viral protein/ml) was added to 4 x 107 cells in a final volume of 2 ml of 
Medium A. Membrane merging was triggered by adjusting the medium pH to 
5.0, either immediately before virus addition, or following a 5 min virus-cell 
incubation at pH 7.4 and 37°C, to allow viral binding (see Results). When 
liposomes were employed as viral target membranes, influenza virus (2 µg of 
viral protein) was added to 200 nmoles of LUVs in a final volume of 2 ml of 
Medium B at pH 7.4 and 37°C. Following a 15 min incubation, the pH was 
lowered to 5.0, and virus-liposome fusion followed. The binding periods 
chosen were those that guaranteed maximal fusion activity in each system. 
In all our experiments, the fluorescence scale was calibrated such that the 
initial fluorescence of R18 labeled virus and cells was set at 0% fluorescence, 
and the value obtained by detergent lysis after each experiment (maximal 
probe dilution) was set at 100% fluorescence. In experiments with CEM cells, 
the detergent octaethyleneglycol dodecyl ether (C12E8, CalBiochem, San 
Diego, CA) was used for calibration purposes, at a final concentration of 2 
mM. For experiments with liposomes, Triton X-100 was employed (1% v/v 
final concentration). In fusion experiments, unbound virions were not 
separated from bound virions contrary to what takes place for binding and cell 
association experiments (see below). 
In some cases, both the extent of dequenching and the initial rate (% 
dequenching/min during the first few seconds following pH reduction) were 
quantified. Fluorescence measurements were performed in a SPEX Fluorolog 
or a Perkin-Elmer LS-50B spectrofluorometer, with excitation at 560 nm and 
emission at 590 nm. The sample chamber was equipped with a magnetic 
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stirring device, and the temperature was maintained at 37ºC with  
a thermostated circulating water bath. 
 
Binding and cell association 
To quantify virus-cell binding, R18-labeled influenza virus (2 µg of viral 
protein) was added to 4 x 107 CEM cells in a final volume of 2 ml of Medium 
A. The virus-cell suspension was then incubated at 37ºC and pH 7.4 for 5 min. 
For virus-liposome binding, influenza virus (2 µg) was added to 400 nmoles of 
MLVs, in a final volume of 2 ml of Medium B and incubated for 15 min at pH 
7.4 and 37ºC. Following these incubations, cells and MLVs were centrifuged, 
and fluorescence was measured in the pellet and supernatant after the addition 
of either C12E8 (2 mM, for CEM cells) or Triton X-100 (1% v/v, for MLVs). 
Binding was calculated as the percentage of fluorescence in the pellet relative 
to total fluorescence (pellet + supernatant).  
Cell association was also measured for influenza virus interactions with CEM 
cells. This monitors not only bound virions at neutral pH (that may, or may 
not, have fused with the target), but also virus that may have associated non-
specifically with the cells following acidification. Therefore, the virus-cell 
incubation at pH 7.4 detailed above was followed by a further 5 min 
incubation at pH 5.0 (37ºC). The cells were then centrifuged, and cell 
association was calculated as described above [10]. In these experiments, total 
fluorescence (Supernatant + Pellet) was equivalent to the 100% calibration 
done in the fusion experiments (not shown). 
 
Enzymatic treatment 
To assess the importance of target membrane sialic acid on influenza virus 
fusion activity towards target membranes, CEM cells were pretreated with 
neuraminidase (NA from Vibrio cholerae, 1 unit/ml specific activity) obtained 
from CalBiochem. Three different concentrations of the enzyme were used 
(0.5, 5 and 50 mu/ml). In all cases, incubation of CEM cells (4 x 107) with NA 
took place in 2 ml Medium A for 20 min at room temperature. Following 
enzymatic treatment, the cells were centrifuged (180 x g, 8 min), washed once 
with Medium A, and ressuspended in 2 ml of the same medium. 
 
Statistical analysis 
Statistical analysis of all the data generated was carried out using the Student-
Newman-Keuls or the Tukey-Kramer multiple comparison tests. 
 
RESULTS 
 
Effect of neuraminidase pretreatment on influenza virus interaction with 
CEM cells 
We have previously shown [10] that treatment of CEM cells with 5 mu/ml of 
NA greatly reduces (but does not totally abolish) influenza virus fusion 
activity towards this particular target  membrane.  However, in  the absence  of 
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viral-cell prebinding (i.e. if R-18 labeled virus is added to CEM cells in  
a medium whose pH is already adjusted to 5), a ten-fold decrease in the 
amount of enzyme added during cell pretreatment is sufficient for the 
maximum inhibitory effect (Fig. 1). A decrease in influenza virus fusion 
activity towards NA-treated cells is already evident following 1 min of 
incubation, and an increase in the incubation time (to 5 min) only results in  
a slight (but significant) increase in the dequenching observed with the control 
cells. Increasing NA concentration to 5 or 50 mu had no further effect (Tab. 1). 
Interestingly, if the virus is prebound to CEM cells at neutral pH prior to 
acidification, pretreatment of cells with 0.5 mu of NA, which was sufficient 
for maximal inhibition using the previous experimental protocol, resulted in 
only a minor (not significant) decrease in fusion activity (Fig. 2). Influenza 
virus fusion with CEM cells was only significantly decreased if the cells had 
been pretreated with at least 5 mu/ml of NA, and a ten-fold increase in enzyme 
concentration had no further effect (Fig. 2). The extents of fluorescence 
dequenching were stable for 1 min following acidification, and no significant 
increases were detected if the incubation was prolonged to 5 min (data not 
shown). 
  
 
 
Fig. 1. Effect of neuraminidase pretreatment of CEM cells on the fusion activity of the 
influenza virus. R18-labeled influenza virus (2 µg viral protein/ml) was added to 4 x 
107 Control (open bars) or NA-pretreated (shaded bars) CEM cells at 37ºC and pH 5.0. 
The extent of fusion, as monitored by the extent of R18 dequenching, was calculated 
after 1 and 5 min, as depicted. In this case, cells were pretreated with 0.5 mu of NA/ml, 
but similar results were obtained with 5 or 50 mu of NA/ml (data not shown). The 
results obtained with NA-treated CEM cells were always significantly lower than with 
Control cells (# and ## p < 0.001). Dequenching quantified 1 min after acidification 
was slightly enhanced by further incubation at low pH when Control cells, but not NA-
treated cells, were used as target membranes for the virus (¥ p < 0.01). The average ± 
S.D. of 6 independent experiments is presented. 
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Fig. 2. Effect of neuraminidase pretreatment of CEM cells on the fusion activity of 
the influenza virus in the presence of virus-cell prebinding. R18-labeled influenza 
virus (2 µg viral protein/ml) was added to 4 x 107 Control (open bars) or NA-
pretreated CEM cells at 37ºC and pH 7.4. In separate experiments, CEM cells were 
pretreated with 0.5 (stripped bars), 5 (shaded bars) or 50 (squared bars) mu of NA/ml 
prior to the fusion assays. Following a 5 min incubation to allow virus-cell binding, 
the medium pH was adjusted to 5.0, and the extent of R18 dequenching calculated 
after 1 min. For each experimental group, the results obtained after a 5 min 
incubation were not statistically different from those calculated after 1 min (not 
shown). The results with Control cells and cells pretreated with 0.5 mu of NA/ml 
were statistically indistinguishable. However, the dequenching observed following 
cell pretreatment with 5 or 50 mu of NA/ml was significantly reduced compared to 
the Control experiments (* p < 0.001). The average ± S.D. of at least 5 independent 
experiments is presented. 
 
The results obtained with the membrane merging assays were mirrored by 
binding results (Fig. 3A). Thus, the binding of influenza virus to CEM cells at 
neutral pH was only mildly (but significantly) affected following cell 
pretreatment with 0.5 mu/ml of NA. A much more pronounced effect was 
obtained following cell pretreatment with both 5 and 50 mu/ml of NA, 
although (as discussed for viral fusion activity) virus-cell binding was never 
completely abolished (Fig. 3A). Interestingly, cell association data (which 
quantifies virions fused or bound after an incubation at low pH) was not as 
clear-cut (Fig. 3B). Thus, while cell pretreatment with 0.5 mu/ml of NA had 
no effect on influenza virus association with CEM cells at pH 5, the effect of  
higher enzyme concentrations, although statistically significant, was minor 
compared to the results obtained with the virus-cell binding assay at neutral 
pH. Indeed, although the binding data discussed here was comparable to 
previously published results, the effect of cell pretreatment with 5 or 50 mu/ml 
of NA on cell association was even slightly lower than what has been 
described [10]. 
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Fig. 3. Effect of neuraminidase pretreatment of CEM cells on influenza virus binding 
and cell association. R18-labeled influenza virus (2 µg viral protein/ml) was added to 
4 x 107 Control (open bars) or NA-pretreated CEM cells at 37ºC and pH 7.4. In 
separate experiments, CEM cells were pretreated with 0.5 (stripped bars), 5 (shaded 
bars) or 50 (squared bars) mu of NA/ml prior to adding the virus. Virus binding (A) 
and Cell association (B) were calculated as described in the Methods section. Binding 
was found to be significantly reduced when NA-treated cells were used as viral targets, 
more noticeably for the pretreatment with higher enzyme concentration (* p < 0.05; ** 
p < 0.001). Cell association relative to control situations was only reduced when the 
cells had been pretreated with higher concentrations of NA (# p < 0.01). The results 
obtained following cell pretreatment with 5 and 50 mu NA/ml were always statistically 
indistinguishable. The average ± S.D. of at least 4 independent experiments is 
presented in all cases. 
 
Our findings with this system are summarized in Tab. 1, where the percentages 
of inhibition found with NA-treated cells relative to the appropriate controls 
are listed for all our experimental designs. As discussed above, CEM treatment 
with the lowest concentration of NA results in either negligible (Fusion with 
binding, Binding, Cell Association) or significant (Fusion without binding) 
inhibition of virus-cell interactions. This is in contrast with what takes place 
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with higher concentrations of NA, where the results are always significantly 
lower than the controls. However, virus-cell association at low pH is always 
very high, and possibly reflects non-functional (probably unspecific) 
interactions. 
 
Tab. 1. The effect of Neuraminidase (NA) treatment of a target membrane on 
interactions between the influenza virus and CEM cellsa. 
 
% of Inhibition Relative to the Control  
NA 0.5 mu/ml NA 5 mu/ml NA 50 mu/ml 
Fusion without Binding 67.5 68.9 70.2 
Fusion with Binding 27.7 83.3 85.7 
Binding 12.9 69.7 70.4 
Cell Association 6.1 23.0 19.7 
aFusion, in the absence or presence of virus-cell prebinding, was monitored for 5 min 
at pH 5.0. Binding and Cell Association were calculated as described in the Methods 
section. The percentage of inhibition was calculated relative to the appropriate controls 
in each case. The average of at least 4 independent experiments is presented.  
 
Effect of the gangliosides GD1a and GT1b on the fusion activity of the 
influenza virus towards lipid vesicles 
The removal of sialic acid residues from CEM cells resulted in a clear 
reduction of influenza virus fusion towards these cells. Therefore, we decided 
to investigate to what extent introducing sialic acid residues, in the form of 
different gangliosides, into a target membrane would affect influenza fusion 
activity. As would be expected, the influenza virus bound poorly to PC/PE 
MLV liposomes that do not contain viral receptors (Tab. 2). The inclusion of 
both GD1a and GT1b in the lipid bilayer lead to a marked potentiation of 
virus-liposome binding, and, although values were higher for GT1b, no 
statistically significant differences were detected between the two gangliosides 
at this level (Tab. 2). However, a higher influenza virus affinity for GT1b has 
previously been reported, using a more sensitive methodology [14]. 
 
Tab. 2. The binding of influenza virus to MLVsa. 
 
  PC/PE GD1a GT1b 
BINDING (%)  17.6 ± 3.1 45.4 ± 3.4 49.8 ± 2.9 
aR18-labeled influenza virus (2 µg) was added to 400 nmoles of MLVs, in a final 
volume of 2 ml at 37ºC. Virus-cell binding was quantified following a 15 min 
incubation at pH 7.4. The average of at least 3 independent experiments (± S.D.) is 
presented.  
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Fig. 4. Effect of gangliosides GD1a and GT1b on the fusion activity of influenza 
towards PC/PE liposomes. R18-labeled influenza virus (2 µg viral protein) was 
added to 200 nmoles of PC/PE LUVs (filled bars), and PC/PE vesicles containing 5 
mol % of GD1a (etched bars) or GT1b (stripped bars) at 37ºC. Following a 15 min 
incubation at pH 7.4, the pH was lowered to 5.0, and virus-liposome fusion followed, 
and was quantified as described in the Materials section. A. The extent of fusion was 
quantified after 15 min at pH 5.0. The result with PC/PE liposomes was significantly 
different from those obtained with ganglioside-containing LUVs (* p < 0.001). No 
significant differences were observed when GD1a or GT1b were used in LUV 
preparation. B. The initial fusion rate was calculated by measuring the rate of 
dequenching in the initial stages of membrane merging (15-40 s after acidification). 
The results obtained with all liposome populations were significantly distinct from 
each other (** p < 0.001). The averages ± S.D. of at least 7 independent experiments 
are presented in all cases. 
 
Similarly, virus fusion with liposomes was also enhanced by the inclusion of 
gangliosides in the target membrane (Fig. 4A). In fact, the extent of influenza 
virus fusion with liposomes lacking viral receptors was quite low, as reported 
previously [6], and only increased significantly following long incubation 
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periods (not shown), i.e. in an experimental situation where unspecific 
exchange of R18 (i.e. transfer of fluorescent probe from labeled virions to the 
target membrane in the absence of true membrane merging) must be taken into 
account [15]. As noted with binding results, the increase in the extent of 
dequenching was significant when either ganglioside was introduced in the 
target membrane, and the results obtained with GD1a and GT1b were also 
statistically identical (Fig. 4A). However, the effect of the two gangliosides 
could be readily differentiated if, instead of the final extent of fusion, the 
initial rate of fluorescence dequenching (i.e. the rate of fusion in the first few 
seconds following low pH-induced membrane merging) was quantified. 
Indeed, although the initial rate of fusion between the influenza virus and 
PC/PE liposomes was again predictably low, it could be potentiated by the 
inclusion of sialic acid-containing gangliosides, in this case with GD1a 
showing a much more pronounced effect than GT1b (Fig. 4B). 
 
DISCUSSION 
 
Although the influenza virus can fuse with membranes composed solely of 
phospholipids [16, 17], viral fusion activity is greatly enhanced by sialic acid 
residues on the target membrane [10, 14, 16-22, 28]. The modulating action of 
sialic acid may take place at several levels, from initial virus-target binding via 
the HA1 subunit to the actual membrane merging step [1-3]. In this latter case, 
sialic acid binding may contribute to membrane proximity, affect low pH-
induced conformational change, or even actively participate in the insertion of 
the fusion peptide into the target membrane [1, 10, 16, 19, 23]. Interestingly, it 
was recently proposed that not all HA proteins at the fusion site may be bound 
to the target membrane via sialic acid receptors, and that sialate binding can 
affect the contribution of an individual HA to membrane merging [24], or to 
dilation of the fusion pore [29]. It should also be noted that the true nature of 
the viral receptors (sialoglycoprotein or sialoglycolipids) is still in debate, with 
recent data pointing specifically to protein anchors [25], although this may 
vary with cell type. 
However, this effect of sialic acid receptors on the target cell surface is likely 
to vary with the experimental approach, depending on how influenza virus 
fusion activity is monitored. Thus, cell pretreatment with very low 
concentrations of exogenous neuraminidase had little effect on virus-cell 
binding at neutral pH, or on virus fusion, provided that fusion was assayed by 
prebinding the virus to the plasma membrane at neutral pH, before triggering 
membrane merging by acidification. However, and contrary to what we 
previously described [10], this same pretreatment was sufficient to reduce 
fusion activity by 67%, provided the virus was directly added to the cells at pH 
5.0. This suggests that the virus HA proteins undergo a pH-dependent 
conformational change prior to contact with the target membrane, and 
inactivate before being able to induce fusion [5, 6]. This inactivation may 
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result in the aggregation of viral particles due to an increase in surface 
hydrophobicity [30], although the inactivated virus still retains the ability to 
bind to target cells, albeit probably non-specifically [5, 10], as apparent from 
the large cell association of virus with CEM cells, even when binding at 
neutral pH is low. If the virus is allowed to contact the target membrane at 
neutral pH before fusion takes place, a much higher concentration of 
exogenous neuraminidase is needed to effectively reduce membrane merging. 
This indicates that target membrane sialic acid can protect the virus from 
inactivation/aggregation, and help convert the HA conformational change into 
useful membrane interactions [10]. Although we cannot discard low pH-
induced changes at the cell surface, which might impair receptor availability, 
our results also seem to show that this effect is not solely dependent on virus-
cell proximity. Indeed, although neuraminidase-treated cells are much less 
adequate targets for the influenza virus, the virus nevertheless binds and 
associates extensively with these cells, both at neutral, and, especially, at 
acidic pH.  
Interestingly, although neuraminidase pretreatment of CEM cells negatively 
mirrored the effect of supplementing liposomes with gangliosides, the same 
conclusion could not be extended to liposome models. Virus-membrane 
binding closely paralleled virus-membrane fusion in this case, i.e. a very low 
level of binding to MLVs without gangliosides corresponded to the residual 
fusion activity monitored in this case. It is possible that this difference may 
result from neuraminidase-insensitive receptors on the surface of CEM cells. 
Studies with model systems have shown that although influenza virus fusion 
activity can be potentiated in the presence of the ganglioside GD1a, this effect 
depended highly on the amount introduced in the target membrane: low 
amounts of ganglioside stimulated fusion, while high amounts partially 
reversed this effect [18]. However, we have always either seen an inhibition of 
fusion activity when different types of target membranes are treated with 
neuraminidase, or seen no effect of enzymatic pretreatment. Therefore, the 
sialic acid content of most biological targets for the virus must be sufficient (if 
suboptimal) for fusion activity, but not inhibitory, although it is also possible 
that the viral neuraminidase may be important if such cases do occur. An 
additional finding deals with the fact that viral fusion kinetics are higher when 
GD1a is introduced into the target membrane, although the virus has been 
shown to bind with greater affinity to GT1b [14]. This raises two possibilities 
which are not mutually exclusive. On the one hand, the delay may represent 
the time needed for the conversion of GT1b into a more suitable receptor via 
the action of the viral neuraminidase [26], or this effect is due exactly to the 
higher binding affinity towards GT1b [14]. The fact that the virus is more 
tightly bound to this receptor constrains its ability to interact efficiently with 
the target membrane. Indeed, recent results point to the fact that tight receptor 
binding may delay the opening of the fusion pore [23, 29]. Taken together, 
these observations imply that there is an optimal interaction between the 
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influenza virus and the target membrane (reflected in both the number of 
receptors, and the affinity of viral binding to each individual receptor) that 
leads to efficient membrane merging. 
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